Skip to content
10-K/A

Annual Report

APELLIS PHARMACEUTICALS, INC.

0001492422-26-000103

← back to feed
Filed
Apr 28, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 21, 2026 128.02M sh